(Q30376553)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397418%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

review article

1 reference

title

Influenza A (H5N1) pandemic prototype vaccine Fluval (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397418%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397418%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Zoltan Vajo

series ordinal

1

1 reference

21 June 2017

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397418%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397418%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397418%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397418%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

619-624

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397418%20AND%20SRC:MED&resulttype=core&format=json

Probable person-to-person transmission of avian influenza A (H5N1)

26 January 2020

cites work

1 reference

Vaccines against avian influenza--a race against time

21 January 2018

1 reference

Oseltamivir resistance during treatment of influenza A (H5N1) infection

21 January 2018

1 reference

Influenza vaccine: the challenge of antigenic drift.

21 January 2018

1 reference

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

21 January 2018

1 reference

Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials." World Health Organization, Geneva, Switzerland, 14-15 February 2008.

21 January 2018

1 reference

Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?

21 January 2018

1 reference

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

21 January 2018

1 reference

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines

21 January 2018

1 reference

Inactivated whole virus influenza A (H5N1) vaccine

21 January 2018

1 reference

Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children.

21 January 2018

1 reference

Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and direct

21 January 2018

1 reference

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions

21 January 2018

1 reference

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

21 January 2018

1 reference

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

21 January 2018

1 reference

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

21 January 2018

1 reference

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

21 January 2018

1 reference

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

21 January 2018

1 reference

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.

21 January 2018

1 reference

Vaccines for seasonal and pandemic influenza.

21 January 2018

1 reference

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses

21 January 2018

1 reference

Strategies for mitigating an influenza pandemic

21 January 2018

1 reference

Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.

21 January 2018

1 reference

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.

21 January 2018

1 reference

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

21 January 2018

1 reference

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

21 January 2018

1 reference

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans

21 January 2018

1 reference

Technology transfer hub for pandemic influenza vaccine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397418%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference